Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 1 of 50 for:    MK-2206
Previous Study | Return to List | Next Study

Dose Defining Study For MK-2206 Combined With Gefitinib In Non Small Cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01147211
Recruitment Status : Unknown
Verified April 2013 by National Taiwan University Hospital.
Recruitment status was:  Active, not recruiting
First Posted : June 22, 2010
Last Update Posted : May 3, 2013
Information provided by (Responsible Party):
National Taiwan University Hospital

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Estimated Primary Completion Date : July 2013
Estimated Study Completion Date : December 2013
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 September 17, 2013
(Canceled - Date Unknown)
September 26, 2013
December 3, 2013
2 August 6, 2014
(Canceled - Date Unknown)
August 8, 2014
August 22, 2014
3 September 2, 2014
September 9, 2014
4 September 12, 2014
September 13, 2014